Barrett & Company’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$105K Hold
719
0.04% 204
2025
Q4
$111K Hold
719
0.04% 201
2025
Q3
$100K Hold
719
0.03% 215
2025
Q2
$96.9K Buy
719
+20
+3% +$2.7K 0.04% 215
2025
Q1
$102K Hold
699
0.04% 187
2024
Q4
$96.2K Buy
699
+136
+24% +$19.9K 0.04% 202
2024
Q3
$86.7K Buy
563
+40
+8% +$6.06K 0.04% 211
2024
Q2
$76.3K Hold
523
0.03% 223
2024
Q1
$77.3K Hold
523
0.04% 225
2023
Q4
$71.3K Buy
523
+9
+2% +$1.17K 0.04% 221
2023
Q3
$66.2K Hold
514
0.04% 221
2023
Q2
$68.2K Hold
514
0.04% 226
2023
Q1
$66.6K Buy
514
+25
+5% +$3.27K 0.04% 219
2022
Q4
$66.5K Hold
489
0.04% 214
2022
Q3
$66.5K Buy
+489
New +$63K 0.04% 214

Other funds holding XLV

Barrett & Company's XLV Position: Q1 2026 in Review

Barrett & Company held its State Street Health Care Select Sector SPDR ETF (XLV) position steady in Q1 2026 at 719 shares worth $105K. The position accounts for 0.04% of the portfolio, ranked #204.

Barrett & Company first reported a position in XLV in Q3 2022 and has held it in 15 quarters since. The position peaked at $111K in Q4 2025. 1,802 funds tracked by Wall St. Rank hold XLV as of Q1 2026.

  • Barrett & Company held 719 shares of State Street Health Care Select Sector SPDR ETF worth $105K as of Q1 2026.
  • Barrett & Company left its State Street Health Care Select Sector SPDR ETF share count unchanged in Q1 2026.
  • State Street Health Care Select Sector SPDR ETF made up 0.04% of Barrett & Company's portfolio in Q1 2026, its #204 holding.
  • Barrett & Company first reported a position in State Street Health Care Select Sector SPDR ETF in Q3 2022 and has held it in 15 quarters since.
  • Barrett & Company's State Street Health Care Select Sector SPDR ETF position peaked at $111K in Q4 2025.
  • 1,802 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.